Haemonetics CorporationHAENYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-10.4%
5Y CAGR-14.5%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-10.4%/yr
vs -6.6%/yr prior
5Y CAGR
-14.5%/yr
Recent acceleration
Acceleration
-3.8pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20252.34-28.8%
20243.28-8.7%
20233.60+10.7%
20223.25-49.7%
20216.46+26.5%
20205.11+6.9%
20194.78+12.0%
20184.27+81.1%
20172.36+20.3%
20161.96-